Collectively, these imaging results indicate that 89Zr‐Df‐YY146 PET, but not 89Zr‐Df‐IgG PET, has the ability to noninvasively detect CD146‐positive melanomas and to precisely select appropriate cases for subsequent CD146‐targeted therapies. Here, MCAM is linked to melanoma.